News

The study, entitled "Vernakalant-facilitated electrical cardioversion: comparison of intravenous vernakalant and amiodarone for drug-enhanced electrical cardioversion of atrial fibrillation after failed electrical cardioversion" authored by Andreas Müssigbrodt et

The grant will help fund an examination of the interaction of over 1400 FDA-Approved drugs and drug-like compounds with a variety of bromodomains, and facilitate the creation of

This patent, with a priority date of 2008, covers screening mechanisms for identification of small molecules that can modulate the function of a nuclear receptor target that was

Data from 50 patients treated at 15 centers are being presented at the European Hematology Association (EHA) Annual Congress in Vienna. A copy of the poster, entitled "Updated

A total of 255 subjects have been enrolled, which exceeds the goal of 250 subjects that were planned for participation. The National Institute of Neurological Disorders and Stroke

After the respective agreement, both Proteus and Boston Children’s Hospital will remain as key members of the collaboration steering committee. The agreement includes about $85m in upfront and

SYN-004 is designed to degrade certain intravenous (IV) beta-lactam antibiotics within the gastrointestinal (GI) tract and maintain the natural balance of the gut microbiome for the prevention of

Resunab is a new synthetic oral drug that has the potential to treat chronic inflammation and fibrosis. Systemic sclerosis causes fibrosis of skin and internal organs, affecting predominately

Under the deal, OA Centers of America will include Gensco’s patented Transdermal products (SpeedGel Rx and LiDORx) as an option to show improved patient outcomes and economic value